| 000 | 01674 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517123209.0 | ||
| 264 | 0 | _c20170412 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1533-712X | ||
| 024 | 7 |
_a10.1097/JCP.0000000000000587 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEnglisch, Susanne | |
| 245 | 0 | 0 |
_aAgomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study. _h[electronic resource] |
| 260 |
_bJournal of clinical psychopharmacology _cDec 2016 |
||
| 300 |
_a597-607 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article | ||
| 650 | 0 | 4 |
_aAcetamides _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntidepressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDepressive Disorder, Major _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 700 | 1 | _aJung, Hanna Sophie | |
| 700 | 1 | _aLewien, Antje | |
| 700 | 1 | _aBecker, Anna | |
| 700 | 1 | _aNowak, Ulrike | |
| 700 | 1 | _aBraun, Hanna | |
| 700 | 1 | _aThiem, Jascha | |
| 700 | 1 | _aEisenacher, Sarah | |
| 700 | 1 | _aMeyer-Lindenberg, Andreas | |
| 700 | 1 | _aZink, Mathias | |
| 773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 36 _gno. 6 _gp. 597-607 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/JCP.0000000000000587 _zAvailable from publisher's website |
| 999 |
_c26570820 _d26570820 |
||